[{"Assets_0_Q2_USD":3902193000.0,"EarningsPerShareBasic_1_Q2_USD":0.58,"EarningsPerShareBasic_2_Q2_USD":1.21,"EarningsPerShareDiluted_1_Q2_USD":0.57,"EarningsPerShareDiluted_2_Q2_USD":1.2,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":108540000.0,"NetIncomeLoss_1_Q2_USD":30705000.0,"NetIncomeLoss_2_Q2_USD":64464000.0,"StockholdersEquity_0_Q2_USD":895966000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":53539000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":53524000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":53098000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":53068000.0,"Ticker":"PBH","CIK":"1295947","name":"PRESTIGE BRANDS HOLDINGS, INC.","OfficialName":"Prestige Consumer Healthcare Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2689675976.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20171102"}]